Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

PaperCitations, authors & open-access status

Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 54 citations, 2024 year and hybrid oa status.

54
Citations
2024
Year
hybrid
OA Status

Related on ScholarIQ

Richard Hobbs
Author
Jane Wolstenholme
Author
Clare Taylor
Author
Ly‐Mee Yu
Author
Richard J. McManus
Author
Nature Medicine
Journal
470M+ articles · free account